ArticleFrontiers in pediatrics2026
Clinical profile and predictors of adverse outcomes in pediatric dengue fever presenting with febrile illness: a prospective observational study in Burao, Somaliland.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dengue fever is a growing public health concern globally, and there is limited pediatric-focused data available in Somaliland. This study aimed to prospectively characterize the clinical profile and identify predictors of adverse outcomes among children presenting with febrile illness, suspected of dengue, in Burao, Somaliland. Methods: This prospective observational study was conducted between September 2025 and April 2026 in pediatric outpatient and inpatient departments of hospitals in Burao. Children aged 0-18 years with acute febrile illness were consecutively enrolled. Clinical assessments and dengue confirmation using rapid diagnostic tests were performed. Disease severity followed WHO 2009 guidelines. Descriptive statistics summarized demographic and clinical characteristics. Multinomial logistic regression, using a prespecified causal framework rather than univariable screening, identified factors associated with recovery, complications, and death. Adjusted relative risk ratios (RRRs) with 95% confidence intervals (CIs) were reported. Results: Of the 186 participants (mean age, 7.86 years; 61.8% male; 83.3% urban residents), common symptoms included rash (60.8%), nausea/vomiting (89.3%), abdominal pain (69.3%), bleeding manifestations (51.1%), and hepatomegaly (47.3%). Most children (83.9%) recovered, 12.4% developed complications, and 3.7% died. Bleeding manifestations were independently associated with a higher relative likelihood of complications than recovery (adjusted relative risk ratio [RRR] = 5.07, 95% CI: 1.42-18.05; Conclusion: Pediatric dengue in Burao has favorable outcomes, but some children develop complications or die. Bleeding manifestations and prolonged fever independently predict adverse outcomes, while higher temperature and abdominal pain have borderline associations. Age, sex, and residence do not predict prognosis. Early recognition of bleeding signs and prolonged fever can improve triage, management, and outcomes. Prospective studies should validate these predictors for dengue care in Somaliland.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.